Skip to content

GLP-1 calculator

Wegovy Weight Loss Calculator

Enter your weight and goal to see what the Wegovy trials found for people like you: the average loss on each dose, the spread across 100 people, and how many reached a goal like yours.

Updated

Used to show how many people in the trial got that far.

Quick answer

In STEP 1, adults without diabetes on Wegovy 2.4 mg lost 14.9% of their body weight on average after 68 weeks, against 2.4% on placebo. On Wegovy 7.2 mg the average was 18.8% after 72 weeks, and on the 25 mg Wegovy pill 13.6% after 64 weeks. With type 2 diabetes, people on 2.4 mg lost 9.6%. About 30 in 100 on 2.4 mg lost 20% or more.

What each medicine did in its trial

Medicine and doseTrialAverage weight lostLost 10% or moreLost 20% or more
Wegovy 2.4 mgSTEP 168 weeks14.9%placebo: 2.4%66 in 10030 in 100
Wegovy 2.4 mgwith type 2 diabetesSTEP 268 weeks9.6%placebo: 3.4%44 in 10013 in 100
Wegovy HD 7.2 mgSTEP UP72 weeks18.8%placebo: 3.9%80 in 10046 in 100
Wegovy pill 25 mgOASIS 464 weeks13.6%placebo: 2.4%60 in 10028 in 100

Log your weight next to your doses

In Mingo you set a weight goal and the weekly pace you're aiming for, see your estimated goal date, and watch each weigh-in on a chart marked with every dose change.

Rated 4.7 out of 5 on the App Store · 1,579 ratings

Where the numbers come from

Every number here is copied from section 14 of the current US Wegovy prescribing information. For each dose it takes one trial: the average weight lost, the share of people who lost at least 5, 10, 15 and 20%, and the placebo group. Your weight is multiplied by those percentages. The label uses one analysis for all of them (everyone who started the trial counts, whether or not they kept taking it), so the doses can be compared fairly. Some websites quote bigger numbers from a second analysis that only counts people who stayed on the medicine; we don’t mix the two.

Wegovy dose Trial Average loss On placebo Lost 20% or more
2.4 mg shot STEP 1, 68 weeks 14.9% 2.4% 30.2 in 100
2.4 mg shot, type 2 diabetes STEP 2, 68 weeks 9.6% 3.4% 12.8 in 100
7.2 mg shot STEP UP, 72 weeks 18.8% 3.9% 45.5 in 100
25 mg pill OASIS 4, 64 weeks 13.6% 2.4% 27.9 in 100

The first weeks are the slowest

Wegovy starts at 0.25 mg and steps up every four weeks, through 0.5, 1 and 1.7 mg, to 2.4 mg in week 17. The low doses are there to limit nausea, not to cause weight loss, so the scale often moves slowly at first. The Wegovy dosage chart shows each step.

The label reports weight at the end of each trial, not week by week, so this calculator doesn’t draw a curve. One marker from another trial: in STEP 4, people had lost 10.6% on average after the first 20 weeks of dose steps (Rubino et al., JAMA 2021).

Is your goal realistic on Wegovy?

The calculator compares your goal with the share of people in the trial who got that far. If your goal is 10% of your weight, about 66 in 100 people on Wegovy 2.4 mg reached it in STEP 1; at 20%, about 30 in 100 did. If you don’t have a goal yet, the ideal weight calculator shows the healthy BMI range for your height, and 5, 10 and 15% steps to aim for on the way.

After the trial ends

The label describes Wegovy as a treatment for chronic weight management: the effect lasts while you take it. One year after stopping, people in the STEP 1 extension had regained about two thirds of what they had lost (Wilding et al., 2022). Any plan to stop or lower your dose is one to make with your doctor. To compare Wegovy with tirzepatide, use the Zepbound weight loss calculator or the GLP-1 weight loss calculator, which shows every medicine side by side.

Track it against the trial

In Mingo you log each Wegovy dose and every weigh-in on one chart that marks each dose change, so you can see how your own numbers compare with what the trial found and show your doctor.

Frequently asked questions

How much weight will I lose on Wegovy?

Nobody can predict it for one person. In STEP 1, adults without diabetes on Wegovy 2.4 mg lost 14.9% on average after 68 weeks; 83.5 in 100 lost at least 5% and 30.2 in 100 lost 20% or more. Enter your weight to see those numbers in pounds or kilos.

How much weight do you lose on Wegovy in the first month?

The first month is on the lowest dose, 0.25 mg, which is meant to get your body used to the medicine, so most of the loss comes later. In STEP 4, people had lost 10.6% on average after the first 20 weeks, which included every dose step up to 2.4 mg.

Is the 7.2 mg dose better than 2.4 mg?

In its trial, adults without diabetes on Wegovy 7.2 mg lost 18.8% on average after 72 weeks, against 3.9% on placebo. That trial had different people and a different length than STEP 1, so the two numbers aren't a direct comparison. Whether a higher dose suits you is a question for your doctor.

Does the Wegovy pill work as well as the shot?

In OASIS 4, adults on the 25 mg Wegovy pill lost 13.6% after 64 weeks, against 2.4% on placebo. The shot's 2.4 mg trial ran 68 weeks and found 14.9%. They're separate trials, so treat them as close, not as a head-to-head result.

Why do people with type 2 diabetes lose less on Wegovy?

In STEP 2, adults with type 2 diabetes on Wegovy 2.4 mg lost 9.6% after 68 weeks, against 3.4% on placebo. The trials found smaller losses with diabetes but don't fully explain why. Tick the diabetes box to see those numbers.

What happens if I stop Wegovy?

Most people regain weight. One year after stopping, people in the STEP 1 extension had regained about two thirds of what they lost. In STEP 4, people switched to placebo after 20 weeks regained 6.9% while those who stayed on lost another 7.9%.

Is this calculator a prediction for me?

No. It shows what happened in trials where everyone also had diet and exercise counseling. Use it to set realistic expectations, and talk to your doctor about your own plan.

Sources

Updated .

  1. Wegovy prescribing information, revised 6/2026, section 14, Tables 8 and 11 (DailyMed)
  2. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med 2021
  3. Rubino D et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance (STEP 4). JAMA 2021
  4. Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab 2022

GLP-1 calculators and dose charts